Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $257,610 - $293,302
-2,704 Closed
0 $0
Q4 2023

May 15, 2024

BUY
$92.27 - $101.54 $249,498 - $274,564
2,704 New
2,704 $273,000
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $2,841 - $3,153
-30 Reduced 0.89%
3,344 $340,000
Q2 2023

Aug 11, 2023

SELL
$92.52 - $104.91 $18,133 - $20,562
-196 Reduced 5.49%
3,374 $340,000
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $4,961 - $5,754
-62 Reduced 1.71%
3,570 $328,000
Q4 2022

Feb 21, 2023

SELL
$75.55 - $92.52 $35,886 - $43,947
-475 Reduced 11.57%
3,632 $329,000
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $19,100 - $22,338
-256 Reduced 5.87%
4,107 $312,000
Q2 2022

Aug 08, 2022

SELL
$80.52 - $93.75 $40,260 - $46,875
-500 Reduced 10.28%
4,363 $369,000
Q1 2022

May 16, 2022

SELL
$80.11 - $90.62 $45,422 - $51,381
-567 Reduced 10.44%
4,863 $427,000
Q4 2021

Feb 16, 2022

BUY
$79.7 - $88.13 $432,771 - $478,545
5,430 New
5,430 $475,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Benchmark Investment Advisors LLC Portfolio

Follow Benchmark Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benchmark Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Benchmark Investment Advisors LLC with notifications on news.